Company / Income Tax
Arbutus Biopharma Corp Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-
FY2025
5-year range
$0 / $4.4M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#120 of 204
Health Care
What the data says
Remained stable around $0 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#85 of 204 in Health CareTop 41% of 204
▼
Key checks
Key Insights
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | - |
| FY2024 | $0 | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $4.4M | - |
| FY2021 | $0 | +100.0% |
| FY2020 | -$12.7M | -195.6% |
| FY2019 | -$4.3M | +82.4% |
| FY2018 | -$24.3M | +0.0% |
| FY2017 | -$24.3M | +76.8% |
| FY2016 | -$105.0M | -548.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026